Pneumonitis After Concurrent Chemoradiation and Immune Checkpoint Inhibition in Patients with Locally Advanced Non-small Cell Lung Cancer

被引：11

作者：

Altan, M. ^{[1
]}

Soto, F. ^{[2
]}

Xu, T. ^{[3
]}

Wilson, N. ^{[2
]}

Franco-Vega, M. C. ^{[4
]}

Clavijo, C. A. Simbaqueba ^{[4
]}

Shannon, V. R. ^{[2
]}

Faiz, S. A. ^{[2
]}

Gandhi, S. ^{[3
]}

Lin, S. H. ^{[3
]}

Lopez, P. ^{[3
]}

Zhong, L. ^{[5
]}

Akhmedzhanov, F. ^{[5
]}

Godoy, M. C. B. ^{[6
]}

Shroff, G. S. ^{[6
]}

Wu, J. ^{[7
]}

Khawaja, F. ^{[8
]}

Kim, S. T. ^{[9
]}

Naing, A. ^{[5
]}

Heymach, J. V. ^{[1
]}

Daniel-Macdougall, C. ^{[10
]}

Liao, Z. ^{[3
]}

Sheshadri, A. ^{[2
,11
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX USA

[4] Univ Texas MD Anderson Canc Ctr, Dept Gen Internal Med, Houston, TX USA

[5] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX USA

[6] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Imaging, Houston, TX USA

[7] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX USA

[8] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX USA

[9] Univ Texas MD Anderson Canc Ctr, Dept Rheumatol, Houston, TX USA

[10] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX USA

[11] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Unit 1462, 1515 Holcombe Blvd, Houston, TX 77030 USA

来源：

CLINICAL ONCOLOGY | 2023年 / 35卷 / 10期

关键词：

Concurrent chemoradiation; immune checkpoint inhibitor; locally advanced non-small cell lung cancer; mortality; pneumonitis; RADIATION PNEUMONITIS; IMMUNOTHERAPY;

D O I：

10.1016/j.clon.2023.07.003

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Aims: Pneumonitis is a common and potentially deadly complication of combined chemoradiation and immune checkpoint inhibition (CRT-ICI) in patients with locally advanced non-small cell lung cancer (LA-NSCLC). In this study we sought to identify the risk factors for pneumonitis with CRT-ICI therapy in LA-NSCLC cases and determine its impact on survival.Materials and methods: We conducted a retrospective chart review of 140 patients with LA-NSCLC who underwent curative-intent CRT-ICI with durvalumab between 2018 and 2021. Pneumonitis was diagnosed by a multidisciplinary team of clinical experts. We used multivariable cause-specific hazard models to identify risk factors associated with grade >= 2 pneumonitis. We constructed multivariable Cox proportional hazard models to investigate the impact of pneumonitis on all-cause mortality.Results: The median age of the cohort was 67 years; most patients were current or former smokers (86%). The cumulative incidence of grade >= 2 pneumonitis was 23%. Among survivors, 25/28 patients had persistent parenchymal scarring. In multivariable analyses, the mean lung dose (hazard ratio 1.14 per Gy, 95% confidence interval 1.03-1.25) and interstitial lung disease (hazard ratio 3.8, 95% confidence interval 1.3-11.0) increased the risk for pneumonitis. In adjusted models, grade >= 2 pneumonitis (hazard ratio 2.5, 95% confidence interval 1.0-6.2, P = 0.049) and high-grade (>= 3) pneumonitis (hazard ratio 8.3, 95% confidence interval 3.0-23.0, P < 0.001) were associated with higher all-cause mortality.Conclusions: Risk factors for pneumonitis in LA-NSCLC patients undergoing CRT-ICI include the mean radiation dose to the lung and pre-treatment interstitial lung disease. Although most cases are not fatal, pneumonitis in this setting is associated with markedly increased mortality.(c) 2023 Published by Elsevier Ltd on behalf of The Royal College of Radiologists.

引用

页码：630 / 639

页数：10

共 31 条

[1] Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC [J].

Antonia, S. J. ;

Villegas, A. ;

Daniel, D. ;

Vicente, D. ;

Murakami, S. ;

Hui, R. ;

Kurata, T. ;

Chiappori, A. ;

Lee, K. H. ;

de Wit, M. ;

Cho, B. C. ;

Bourhaba, M. ;

Quantin, X. ;

Tokito, T. ;

Mekhail, T. ;

Planchard, D. ;

Kim, Y. -C. ;

Karapetis, C. S. ;

Hiret, S. ;

Ostoros, G. ;

Kubota, K. ;

Gray, J. E. ;

Paz-Ares, L. ;

Carpeno, J. de Castro ;

Faivre-Finn, C. ;

Reck, M. ;

Vansteenkiste, J. ;

Spigel, D. R. ;

Wadsworth, C. ;

Melillo, G. ;

Taboada, M. ;

Dennis, P. A. ;

Ozguroglu, M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (24) :2342-2350

[2] Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer [J].

Antonia, S. J. ;

Villegas, A. ;

Daniel, D. ;

Vicente, D. ;

Murakami, S. ;

Hui, R. ;

Yokoi, T. ;

Chiappori, A. ;

Lee, K. H. ;

de Wit, M. ;

Cho, B. C. ;

Bourhaba, M. ;

Quantin, X. ;

Tokito, T. ;

Mekhail, T. ;

Planchard, D. ;

Kim, Y. -C. ;

Karapetis, C. S. ;

Hiret, S. ;

Ostoros, G. ;

Kubota, K. ;

Gray, J. E. ;

Paz-Ares, L. ;

de Castro Carpeno, J. ;

Wadsworth, C. ;

Melillo, G. ;

Jiang, H. ;

Huang, Y. ;

Dennis, P. A. ;

Ozguroglu, M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (20) :1919-1929

[3] Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non-Small-Cell Lung Cancer [J].

Auperin, Anne ;

Le Pechoux, Cecile ;

Rolland, Estelle ;

Curran, Walter J. ;

Furuse, Kiyoyuki ;

Fournel, Pierre ;

Belderbos, Jose ;

Clamon, Gerald ;

Ulutin, Hakki Cuneyt ;

Paulus, Rebecca ;

Yamanaka, Takeharu ;

Bozonnat, Marie-Cecile ;

Uitterhoeve, Apollonia ;

Wang, Xiaofei ;

Stewart, Lesley ;

Arriagada, Rodrigo ;

Burdett, Sarah ;

Pignon, Jean-Pierre .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (13) :2181-2190

[4] Combined effect of lung function level and decline increases morbidity and mortality risks [J].

Baughman, Penelope ;

Marott, Jacob L. ;

Lange, Peter ;

Martin, Christopher J. ;

Shankar, Anoop ;

Petsonk, Edward L. ;

Hnizdo, Eva .

EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2012, 27 (12) :933-943

[5] A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer [J].

Bruni, Alessio ;

Scotti, Vieri ;

Borghetti, Paolo ;

Vagge, Stefano ;

Cozzi, Salvatore ;

D'Angelo, Elisa ;

Levra, Niccolo Giaj ;

Fozza, Alessandra ;

Taraborrelli, Maria ;

Piperno, Gaia ;

Vanoni, Valentina ;

Sepulcri, Matteo ;

Trovo, Marco ;

Nardone, Valerio ;

Lattanzi, Elisabetta ;

Selman, Said Bou ;

Bertolini, Federica ;

Franceschini, Davide ;

Agustoni, Francesco ;

Jereczek-Fossa, Barbara Alicja ;

Magrini, Stefano Maria ;

Livi, Lorenzo ;

Lohr, Frank ;

Filippi, Andrea Riccardo .

FRONTIERS IN ONCOLOGY, 2021, 11

[6] Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy [J].

Fay, M ;

Tan, A ;

Fisher, R ;

Mac Manus, M ;

Wirth, A ;

Ball, D .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (05) :1355-1363

[7] Locally-advanced non-small cell lung cancer: shall immunotherapy be a new chance? [J].

Filippi, Andrea Riccardo ;

Di Muzio, Jacopo ;

Badellino, Serena ;

Mantovani, Cristina ;

Ricardi, Umberto .

JOURNAL OF THORACIC DISEASE, 2018, 10 :S1461-S1467

[8] Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non-Small-Cell Lung Cancer Who Received Programmed Death 1 Inhibitors [J].

Fukihara, Jun ;

Sakamoto, Koji ;

Koyama, Junji ;

Ito, Takayasu ;

Iwano, Shingo ;

Morise, Masahiro ;

Ogawa, Masahiro ;

Kondoh, Yasuhiro ;

Kimura, Tomoki ;

Hashimoto, Naozumi ;

Hasegawa, Yoshinori .

CLINICAL LUNG CANCER, 2019, 20 (06) :442-+

[9] Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study [J].

Girard, Nicolas ;

Bar, Jair ;

Garrido, Pilar ;

Garassino, Marina C. ;

McDonald, Fiona ;

Mornex, Francoise ;

Filippi, Andrea R. ;

Smit, Hans J. M. ;

Peters, Solange ;

Field, John K. ;

Christoph, Daniel C. ;

Sibille, Anne ;

Fietkau, Rainer ;

Haakensen, Vilde D. ;

Chouaid, Christos ;

Markman, Ben ;

Hiltermann, T. Jeroen N. ;

Taus, Alvaro ;

Sawyer, William ;

Allen, Allison ;

Chander, Pratibha ;

Licour, Muriel ;

Solomon, Benjamin .

JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (02) :181-193

[10] Locally advanced non-small cell lung cancer: The past, present, and future [J].

Govindan, Ramaswamy ;

Bogart, Jeffrey ;

Vokes, Everett E. .

JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (08) :917-928

← 1 2 3 4 →